hematology

Welcome to the 'hematology' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'hematology'.

Latest blogosphere posts tagged “hematology”

• FDA Approves Kalbitor For Treating Potentially Life-Threatening Attacks Of Hereditary Angioedema

  
  Health News from Medical News Today — Authority: 695
  The U.S. Food and Drug Administration approved Kalbitor (ecallantide) on Dec. 1 to treat sudden and potentially life-threatening fluid buildup that can occur in people with a rare genetic condition known as hereditary angioedema (HAE). HAE is caused by a defect in the blood protein C1 esterase-inhibitor, which plays ...
  2 days ago

• Late Preterm Infants Remain At Risk Of Bloodstream Infection

  
  Health News from Medical News Today — Authority: 695
  Sepsis is a serious infection that is a major cause of death in very premature infants. But sepsis is also a threat in "late preterm" infants born just a few weeks prematurely, according to a study in the December issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & ...
  2 days ago

• 51st Annual Meeting Of The American Society Of Hematology Will Highlight Research And Policy Changes Affecting Medical Practice And Patient Care

  
  Health News from Medical News Today — Authority: 695
  The American Society of Hematology (ASH), the worlds largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Meeting from December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. The meeting will showcase the latest research and ...
  2 days ago

• ASH To Encourage High School Students To Pursue Biomedical Research Through Special Symposium And Science Curriculum

  
  Health News from Medical News Today — Authority: 695
  The American Society of Hematology (ASH) will host its annual High School Student Symposium at the New Orleans Marriott on Thursday, December 3, at 8:00 a.m. CST. The symposium, which encourages an interest in hematology, the biological sciences, and medical research, is held in conjunction with the Societys 51st ...
  2 days ago

• What Is Vitamin B12 Deficiency? What Causes Vitamin B12 Deficiency?

  
  Health News from Medical News Today — Authority: 695
  Vitamin B12 is crucial for the proper formation of red blood cells, as well as the health of nerve tissue. Vitamin B12 deficiency, or B12 deficiency, if left untreated can result in anemia, as well as irreversible nerve and brain damage. A lack of vitamin B12 in the blood can lead to a blood disorder called ...
  2 days ago

• Dyax Announces FDA Approval Of KALBITOR(R) For The Treatment Of Acute Attacks Of Hereditary Angioedema In Patients 16 Years Of Age And Older

  
  Health News from Medical News Today — Authority: 695
  Dyax Corp. (NASDAQ:DYAX) announced that the U.S. Food and Drug Administration (FDA) has granted approval for KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. HAE is a rare, genetic disorder characterized by severe, debilitating and often ...
  2 days ago

• Acute Myelogenous Leukemia (Contemporary Hematology) by Judith E. Karp

  
  Free Your Mind All Free Download — Authority: 165
  Acute Myelogenous Leukemia | Humana Press | 2007 | ISBN: 1588296210 | 426 pages | PDF | 41 MB Acute Myelogenous Leukemia is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML ...
  3 days ago

• 13 Biotechs to Watch for at Hematology Conference

  
  Topblank — Authority: 166
  13 Biotechs to Watch for at Hematology Conference
  5 days ago

• Doha: Hematologist

  
  International Jobs for Physicians, Nurses and Allied Health - atlasmed.com — Authority: 147
  Our client is a new 250 bed modern state of the art hospital in Doha, Qatar on the Arabian Gulf. The hospital has a vacancy for Consultant Hematologist When required – Immediate or latest by January 2010   Qualification – American Board in Pathology, or Royal College Degree in Pathology before 1996 or ...
  6 days ago

• Novartis Gains Rights To Two Oral Targeted Investigational Therapies Focusing On Patients With Life-threatening Blood Disorders And Cancers

  
  Health News from Medical News Today — Authority: 695
  Novartis has gained exclusive rights to two oral targeted investigational therapies for patients with a range of life-threatening blood disorders and cancers that currently do not have effective treatment options.
  1 week ago

• ASH Honors Rep. Doris O. Matsui (D-CA) And Melanie Bloom For Their Public Service, Leadership, And Commitment To Biomedical Research

  
  Health News from Medical News Today — Authority: 695
  The American Society of Hematology (ASH), the worlds largest professional society of blood specialists, will recognize a member of the U.S. House of Representatives and the national spokesperson for the Coalition to Prevent Deep-Vein Thrombosis for their efforts to promote biomedical research.
  1 week ago

• ASH Announces 2009 Merit Award Winners

  
  Health News from Medical News Today — Authority: 695
  The American Society of Hematology (ASH) is pleased to recognize the following abstract presenters with the highest scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and post-doctoral fellow. Merit Award winners receive a $500 honorarium plus annual ...
  1 week ago

• Initiative Could Result In Paradigm Shift In The Care Of Sickle Cell Patients

  
  Health News from Medical News Today — Authority: 695
  The Medical College of Georgia is leading an initiative that could result in a paradigm shift in the care of patients with sickle cell disease.
  1 week ago

• Gloucester Pharmaceuticals To Present Positive Results From Multiple Studies Of ISTODAX(R) At The ASH Annual Meeting

  
  Health News from Medical News Today — Authority: 695
  Gloucester Pharmaceuticals announced multiple presentations from clinical and preclinical studies of ISTODAX® (romidepsin) at the upcoming 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, Louisiana, at the Ernest N. Morial Convention Center, December 5 - 8, 2009. ISTODAX, a novel ...
  1 week ago

• New Science Program Teaches High School Students About Blood And Career Opportunities In The Field Of Hematology

  
  Health News from Medical News Today — Authority: 695
  The American Society of Hematology (ASH) and Scholastic, the global childrens publishing, education, and media company, are launching "Explore the Mystery of Blood," a dynamic science curriculum designed to spark interest in the fields of science and medicine, in addition to exposing students to exciting career ...
  1 week ago

• The 4th Annual Georgetown Jingle

  
  Ask Miss A — Authority: 476
  The Four Seasons Hotel Washington, DC, JDS Designs, and The Washington Design Center together with some of the Washington area’s most recognized interior designers present the fourth annual Georgetown Jingle at the Four Seasons Hotel in Washington, DC on Sunday, December 13, 2009, from 4-8 p.m. The Georgetown Jingle ...
  2 weeks ago

• FDA Announces New Warning On Plavix: Avoid Use With Prilosec/Prilosec OTC

  
  Health News from Medical News Today — Authority: 695
  Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17. New data suggest that when patients take both Prilosec and Plavix, Plavixs ability to block platelet aggregation ...
  2 weeks ago

• New treatment for hemophilia launched in India

  
  Thaindian News — Authority: 724
  New Delhi, Nov 18 (IANS) A new genetically engineered treatment for hemophilia, a dreaded disease where blood doesn’t clot, was launched here Wednesday by a private pharmaceutical company.Unlike other procedures, this treatment won’t require donor blood for transfusion.The treatment based on ‘Recombinate’, a ...
  2 weeks ago

• 
  JAMA — Authority: 440
  
  2 weeks ago

• Cerus Corporation Receives FDA Blood Products Advisory Committee Guidance For Proposed INTERCEPT Blood System Phase III Trial Design

  
  Health News from Medical News Today — Authority: 695
  Cerus Corporation (NASDAQ:CERS) announced that the FDAs Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.
  2 weeks ago

Comments about hematology